retatrutide news today october 2025 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide, an experimental weight-loss drug,

Medications like Ozempic and Wegovy work by binding to the same receptor sites as the natural GLP-1 hormone, amplifying its satiety signal (ref)

At first glance, it seems like your average emollient plant oil: it looks like an oil and it's nourishing and moisturizing to the skin but if we dig a bit deeper, it turns out that jojoba oil is really special and unique : technically - or rather chemically - it's not an oil but a wax ester (and calling it an oil is kind of sloppy)

The GT Plus assay results in these samples were as follows (Table 4): (i) the genotype 1 subtype was resolved in seven specimens and results were confirmed either by the reference method in the targeted core region ( n = 6

Menos grasa

If you dont have a qualifying indication and youre looking at these drugs purely for pain management, thats a significantly harder case to make given the current evidence